Valuation: genedrive plc

Market Cap 20.87M 27.92M 24.85M 23.03M 39.23M 2.65B 39.88M 276M 109M 1.38B 105M 103M 4.42B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.34M 23.45M 21.73M 37.01M 2.5B 37.62M 261M 102M 1.31B 98.8M 96.75M 4.17B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
55.04%
Yield 2024 *
-
Yield 2025 -
Current month-10.42%
1 month-14.00%
3 months+2.38%
6 months+7.50%
Current year+22.86%
1 week 1
Extreme 1
1.15
1 month 1
Extreme 1
1.25
Current year 0.75
Extreme 0.75
1.55
1 year 0.42
Extreme 0.425
1.55
3 years 0.19
Extreme 0.19
12.3
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-05
Director of Finance/CFO 48 2022-04-06
Director TitleAgeSince
Director/Board Member 56 2023-09-10
Director/Board Member 48 2022-04-06
Director/Board Member 57 2026-05-25
Date Insider Type Main position Quantity % Market Cap. Importance
12/20/24 Buy

Chief Financial Officer

1,000,000 0.1841%
12/20/24 Free 400,000 0.0736%
12/20/24 Buy

Chief Executive Officer

1,135,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+115.00%-88.83% 22.99M
+1.18%+3.67%+26.39%+48.03% 251B
-0.08%+0.63%+7.61%+8.94% 158B
+1.11%+3.78%-4.46%+64.10% 153B
+1.18%+5.24%-54.66%-8.93% 65.29B
+0.59%+5.65%+11.46%+59.02% 51.29B
+1.00%+3.81%-14.33%-9.91% 51.23B
+1.23%+3.54%+17.27%+27.07% 50.27B
+1.83%+0.82%+20.99%+58.39% 47.9B
+1.97%+3.18%+29.04%+74.59% 42.67B
Average +0.26%+2.55%+15.43%+23.25% 87.07B
Weighted average by Cap. -0.32%+2.40%+7.52%+37.40%

Financials

2024 2025
Net sales 501K 670K 597K 553K 942K 63.49M 957K 6.63M 2.61M 33.23M 2.51M 2.46M 106M 954K 1.28M 1.14M 1.05M 1.79M 121M 1.82M 12.63M 4.96M 63.27M 4.79M 4.69M 202M
Net income -7.08M -9.46M -8.42M -7.81M -13.3M -897M -13.52M -93.68M -36.8M -469M -35.5M -34.77M -1.5B -5.23M -7M -6.23M -5.77M -9.83M -663M -10M -69.27M -27.21M -347M -26.25M -25.7M -1.11B
Net Debt -5.17M -6.91M -6.15M -5.7M -9.71M -655M -9.88M -68.45M -26.89M -343M -25.94M -25.4M -1.09B -1.18M -1.58M -1.41M -1.3M -2.22M -150M -2.26M -15.65M -6.15M -78.39M -5.93M -5.81M -250M
Projected Income Statement - Annual - genedrive plc
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
26-10-20 GBX 1.075 0.00% 678,594
26-10-19 GBX 1.075 +2.38% 1,269,451
26-10-16 GBX 1.050 -4.55% 4,359,996
26-10-15 GBX 1.100 +4.76% 1,230,437
26-10-14 GBX 1.050 -2.33% 1,048,959

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - genedrive plc